Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Exploring drug response in K-Ras disease mutants - An NMR-based structure activity study
FY 2023-24
Summary
KRAS, a vital member of the Ras subfamily, is the most frequently mutated oncogene in human cancers. Despite originally being considered “undruggable”, understanding K-Ras’ behaviour and its response to drugs has ignited significant interest. The objective of this project is to investigate the intricate relationship between functional states of K-Ras and its disease mutants, ligand binding sites, and the effects of drug binding. The experimental approach involves the expression and purification of K-Ras mutants and the use of a shift reagent which reacts orthogonally towards the protein’s N-terminal cysteine. The shift reagent facilitates the delineation of functional states and improves upon the study of interaction dynamics between the drug and the protein.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
506144
Name
Khan Afnan
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Exploring drug response in K-Ras disease mutants - An NMR-based structure activity study
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cancer; Covalent Inhibitors; Disease Mutants; Drug Signatures; Functional States; Interaction Dynamics; K-Ras; Paramagnetic Shift Reagent; Protein Nmr; Structure Activity Relationship (Sar)
Abstract
KRAS, a vital member of the Ras subfamily, is the most frequently mutated oncogene in human cancers. Despite originally being considered “undruggable”, understanding K-Ras’ behaviour and its response to drugs has ignited significant interest. The objective of this project is to investigate the intricate relationship between functional states of K-Ras and its disease mutants, ligand binding sites, and the effects of drug binding. The experimental approach involves the expression and purification of K-Ras mutants and the use of a shift reagent which reacts orthogonally towards the protein’s N-terminal cysteine. The shift reagent facilitates the delineation of functional states and improves upon the study of interaction dynamics between the drug and the protein.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Khan, Afnan
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~